Cancer Clinical Trial - Corcept - CORT125134‐553

Status:

Open and enrolling

Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (RELIANT) - CONDITION(S): Pancreatic cancer

Drug

Relacorilant + nab‐paclitaxel

Trial Type

Treatment

Condition

Pancreatic cancer

Keywords

Pancreatic cancer | Corcept